HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
UNICEF commits to:
133. Increase access to child testing and case finding. Specifically in 2023 UNICEF will:
i. Host a technical consultation with key global partners around enhanced strategies to identify undiagnosed children living with HIV
ii. Ensure that in emergency contexts (eg currently in Ukraine), children and families have access to a continuous supply of essential HIV diagnostics
134. Support decentralized multi-disease POC antenatal testing to advance dual and triple elimination of HIV.
135. Strengthen diagnostic literacy and work in partnership with CSOs, CBOs and/or FBOs to support advocacy for diagnostics and generate demand for testing.
136. Support data-driven optimization of national diagnostics networks including laboratory-based, near point-of-care and point-of-care technologies and to optimize investment and create an enabling environment for diagnosis of HIV and other conditions.
All partners commit to:
163. Address inequities by tackling the stigma and discrimination in communities, schools, and healthcare settings that prevent children living with HIV from accessing testing and treatment.
164. Increase literacy about CD4 testing and viral load and promote a client-centred approach to support expansion of access to viral load for pregnant and breastfeeding women and children on treatment, including at the point-of-care.
165. Review and assess emerging co-infections for immunocompromised infants and children, including those with advanced HIV disease, such as severe bacterial infections, fungal infections, and others for country consideration and implementation.
166. Engage affected communities for input and guidance on investment and programmatic priorities, provide support to in-country civil society organizations to engage in advocacy and demand creation for new tools, and ensure data is publicly available to support communities and civil society to monitor progress regarding uptake and implementation of essential diagnostic tools.
133. June 2023: UNICEF hosted an expert consultation to scale up HIV case finding and together with partners is in the final stages of publishing a Technical note to facilitate and operationalize HIV case finding among children
136. June 2023: A comprehensive diagnostic toolkit "Let's Test" https://lets-test.org/to support advocacy for improved access to diagnostics around the world was finalized and launched in June, 2023. In partnership with WHO, UNICEF is advancing the Triple Elimination Initiative including diagnosis and VL testing for HBV and multiplex testing for HIV and syphilis including through enhancing procurement of HIV-syphilis dual rapid tests
UNICEF commits to:
304. UNICEF SD commits to support uptake of novel paediatric treatment options by inclusion of fixed dose ALD (expected to be prequalified 6/2023) and other new products when available, in long term agreements with manufacturers that offer flat pricing for children everywhere living in LMICs.
305. Work with countries to increase uptake of newer drugs and formulations through demand creation for paediatric treatment services and generation of age disaggregated data to inform supply planning and forecasting.
306. UNICEF commits to collaborate with GAP-f partners to develop and validate a product-agnostic toolkit to support and accelerate the introduction of new paediatric drugs and formulations. The toolkit will include stakeholder planning and advocacy elements and will be disseminated by October, 2023.
307. UNICEF commits to collaborate with GAP-f partners to review and update the pDTG transition tracker and expand the countries covered by the tracker from 30 to 59 by Q3 2023.
305. June 2023: UNICEF has been working to develop tools and systems to support rollout of new products including for ALD
307. June 2023:
-
UNICEF as a member of the GAPf network has worked to promote new products including pDTG and pALD formulations.
-
UNICEF has worked at country level to push pDTG formulation uptake and 65% of UNICEFs 37 priority countries are implementing pDTG medication.
UNICEF commits to:
451. Advocate and support Governments for increased paediatric TB case-finding and access to child-friendly treatment as a core member of the TB Child and Adolescent Working Group and the TB PADO.
452. Support national governments to optimize the integration of TB with child health, HIV, and nutrition services.
-